Skip to main content
. 2021 Jan 5;35(6):453–463. doi: 10.1093/mutage/geaa032

Table 1.

Carcinogen concentrations used to treat FE1 cells for the FE1 cell mutagenicity assay based on cell viability (% of control) determined by crystal violet staining

Cell viability (% of control) Acrylamide (mM) Glycidamide −S9 (mM) PhIP (μM) N-OH-PhIP −S9 (μM) 4-ABP (μM) N-OH-4-ABP −S9 (μM)
−S9 +S9 −S9 +S9 −S9 +S9
100 2 0.5 1 25 0.625 1.25 100 100 1
80 3 1 1.5 50 1.25 2 200 300 1.5
60 4 2 2 100 2.5 2.5 300 400 3
40 8 3 2.5 200 2.75 4 500 500 3.5
20 10 4 3.5 250 5 5 550 520 4.5